FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher van Dyck

Research Profile

Procedures

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Neuropsychological Tests

Co-author Network

Publications

TOP 3
Jonas Hannestad; Jean-Dominique Gallezot; Beata Planeta-Wilson; Shu-Fei Lin; Wendol A Williams; Christopher H van Dyck; Robert T Malison; Richard E Carson; Yu-Shin Ding
Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo.
Avis Brennan Hains; Mai Anh T Vu; Paul K Maciejewski; Christopher H van Dyck; Melissa Gottron; Amy F T Arnsten
Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress.
Lekshmi Santhosh; Kristina M Estok; Rebecca S Vogel; Gilles D Tamagnan; Ronald M Baldwin; effie mitsis; Martha G MacAvoy; Julie K Staley; Christopher H van Dyck
Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher van Dyck (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Jonas Hannestad; Jean-Dominique Gallezot; Beata Planeta-Wilson; Shu-Fei Lin; Wendol A Williams; Christopher H van Dyck; Robert T Malison; Richard E Carson; Yu-Shin Ding
Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo.
Biological psychiatry 2010;68(9):854-60.
2009: Avis Brennan Hains; Mai Anh T Vu; Paul K Maciejewski; Christopher H van Dyck; Melissa Gottron; Amy F T Arnsten
Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(42):17957-62.
2009: Lekshmi Santhosh; Kristina M Estok; Rebecca S Vogel; Gilles D Tamagnan; Ronald M Baldwin; effie mitsis; Martha G MacAvoy; Julie K Staley; Christopher H van Dyck
Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET.
Psychiatry research 2009;173(3):212-7.
2009: effie mitsis; Kristina M Reech; Frederic Bois; Gilles Tamagnan; Martha G MacAvoy; John P Seibyl; Julie K Staley; Christopher H van Dyck
123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(9):1455-63.
2009: effie mitsis; Kelly P Cosgrove; Julie K Staley; Frederic Bois; Erin B Frohlich; Gilles D Tamagnan; Kristina M Estok; John P Seibyl; Christopher H van Dyck
Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT.
Neurobiology of aging 2009;30(9):1490-7.
2009: Christopher H van Dyck; Jeffrey M Lyness; Robert M Rohrbaugh; Alan P Siegal
Cognitive and psychiatric effects of vitamin B12 replacement in dementia with low serum B12 levels: a nursing home study.
International psychogeriatrics / IPA 2009;21(1):138-47.
2009: Kristina F Zdanys; Timothy G Kleiman; Huiping Zhang; Fatih Ozbay; Martha G MacAvoy; Joel Gelernter; Christopher H van Dyck
BDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: an exploratory study.
Journal of Alzheimer's disease : JAD 2009;17(4):887-98.
2008: J J Sevigny; J M Ryan; Christopher H van Dyck; Y Peng; C R Lines; M L Nessly
Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.
Neurology 2008;71(21):1702-8.
2008: Christopher H van Dyck
Imaging microglial activation in Alzheimer's disease: what does it mean?
Biological psychiatry 2008;64(10):833-4.
2008: Paul S Aisen; Lon S Schneider; Mary Sano; Ramon Diaz-Arrastia; Christopher H van Dyck; Myron Weiner; Teodoro Bottiglieri; Shelia Jin; Karen T Stokes; Ronald Thomas; Leon J Thal
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2008;300(15):1774-83.
2008: Christopher H van Dyck; RA Avery; Martha G MacAvoy; Kenneth Marek; Donald M Quinlan; Ronald M Baldwin; John P Seibyl; Robert B Innis; Amy F T Arnsten
Striatal dopamine transporters correlate with simple reaction time in elderly subjects.
Neurobiology of aging 2008;29(8):1237-46.
2008: Jason H T Karlawish; Scott Y H Kim; David S. Knopman; Christopher H van Dyck; Bryan D James; Daniel Marson
Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(7):568-74.
2008: Jason H T Karlawish; Scott Y H Kim; David S. Knopman; Christopher H van Dyck; Bryan D James; Daniel Marson
The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(3):240-7.
2007: Kelly P Cosgrove; effie mitsis; Frederic Bois; Erin Frohlich; Gilles Tamagnan; Erica Krantzler; Edward Perry; Paul K Maciejewski; C Neill Epperson; Sharon Allen; Stephanie O'Malley; Carolyn M Mazure; John P Seibyl; Christopher H van Dyck; Julie K Staley
123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phase.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(10):1633-40.
2007: Rajesh R Tampi; Christopher H van Dyck
Memantine: efficacy and safety in mild-to-severe Alzheimer's disease.
Neuropsychiatric disease and treatment 2007;3(2):245-58.
2007: Christopher H van Dyck; Pierre N. Tariot; Barnett Meyers; E Malca Resnick
A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.
Alzheimer disease and associated disorders 2007;21(2):136-43.
2007: effie mitsis; Kelly P Cosgrove; Julie K Staley; Erin Frohlich; Frederic Bois; Gilles Tamagnan; Kristina M Estok; John P Seibyl; Christopher H van Dyck
[123I]5-IA-85380 SPECT imaging of beta2-nicotinic acetylcholine receptor availability in the aging human brain.
Annals of the New York Academy of Sciences 2007;1097():168-70.
2007: Kristina F Zdanys; Timothy G Kleiman; Martha G MacAvoy; Benjamin T Black; Tracy E Rightmer; Monique Grey; Katherine S Garman; Rajesh R Tampi; Joel Gelernter; Christopher H van Dyck
Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(1):171-9.
2006: Brian P Ramos; David Stark; Luis Verduzco; Christopher H van Dyck; Amy F T Arnsten
Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals.
Learning & memory (Cold Spring Harbor, N.Y.) 2006;13(6):770-6.
2006: Frederick A Schmitt; Christopher H van Dyck; Christine H Wichems; Jason T Olin
Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis.
Alzheimer disease and associated disorders 2006;20(4):255-62.
2006: Michael Basso; Joel Gelernter; John Yang; Martha G MacAvoy; Pradeep Varma; Richard A Bronen; Christopher H van Dyck
Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.
Neurobiology of aging 2006;27(10):1416-24.
2006: Julie K Staley; Suchitra Krishnan-Sarin; Kelly P Cosgrove; Erica Krantzler; Erin Frohlich; Edward Perry; Joel A Dubin; Kristina Estok; Eric Brenner; Ronald M Baldwin; Gilles Tamagnan; John P Seibyl; Peter Jatlow; Marina R Picciotto; Edythe D London; Stephanie O'Malley; Christopher H van Dyck
Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(34):8707-14.
2006: Huiping Zhang; Fatih Ozbay; Jaakko Lappalainen; Henry R Kranzler; Christopher H van Dyck; Dennis S Charney; Lawrence H Price; Steven M Southwick; Bao-Zhu Yang; Ann Rasmussen; Joel Gelernter
Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2006;141B(4):387-93.
2006: Christopher H van Dyck; Frederick A Schmitt; Jason T Olin
A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(5):428-37.
2006: Michael Basso; John Yang; Lauren Warren; Martha G MacAvoy; Pradeep Varma; Richard A Bronen; Christopher H van Dyck
Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease.
Psychiatry research 2006;146(3):251-61.
2006: Timothy Kleiman; Kristina Zdanys; Benjamin Black; Tracy Rightmer; Monique Grey; Katherine Garman; Martha G MacAvoy; Joel Gelernter; Christopher H van Dyck
Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Dementia and geriatric cognitive disorders 2006;22(1):73-82.
2006: Lingjun Zuo; Christopher H van Dyck; Xingguang Luo; Henry R Kranzler; Bao-Zhu Yang; Joel Gelernter
Variation at APOE and STH loci and Alzheimer's disease.
Behavioral and brain functions : BBF 2006;2():13.
2005: Susan E Best; Philip M Sarrel; Robert T Malison; Marc Laruelle; Sami S Zoghbi; Ronald M Baldwin; John P Seibyl; Robert B Innis; Christopher H van Dyck
Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle.
Psychopharmacology 2005;183(2):181-9.
2005: Julie K Staley; Christopher H van Dyck; David Weinzimmer; Eric Brenner; Ronald M Baldwin; Gilles Tamagnan; Patrizia Riccardi; effie mitsis; John P Seibyl
123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(9):1466-72.
2005: Julie K Staley; Christopher Gottschalk; Ismene L Petrakis; Ralitza Gueorguieva; Stephanie O'Malley; Ronald Baldwin; Peter Jatlow; Nicolaas P L G Verhoeff; Edward Perry; David Weinzimmer; Erin Frohlich; Elizabeth Ruff; Christopher H van Dyck; John P Seibyl; Robert B Innis; John H Krystal
Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to features of alcohol dependence and cigarette smoking.
Archives of general psychiatry 2005;62(8):877-88.
2005: Ronald C. Petersen; Ronald Thomas; Michael Grundman; David A Bennett; Rachelle S Doody; Steven H Ferris; Douglas Galasko; Shelia Jin; Jeffrey A Kaye; Allan Levey; Eric Pfeiffer; Mary Sano; Christopher H van Dyck; Leon J Thal
Vitamin E and donepezil for the treatment of mild cognitive impairment.
The New England journal of medicine 2005;352(23):2379-88.
2005: Adam S Fleisher; Michael Grundman; Clifford R Jack; Ronald C. Petersen; Curtis Taylor; Hyun T Kim; Denise H B Schiller; Victor Bagwell; Drahomira Sencakova; Myron Weiner; Charles DeCarli; Steven T DeKosky; Christopher H van Dyck; Leon J Thal
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment.
Archives of neurology 2005;62(6):953-7.
2005: Christopher H van Dyck; Robert T Malison; Leslie K Jacobsen; John P Seibyl; Julie K Staley; Marc Laruelle; Ronald M Baldwin; Robert B Innis; Joel Gelernter
Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(5):745-51.
2005: Illana Gozes; Bruce H Morimoto; Jacqueline Tiong; Anthony Fox; Karole Sutherland; David Dangoor; Miriam Holser-Cochav; Karin Vered; Paul Newton; Paul S Aisen; Yasuji Matsuoka; Christopher H van Dyck; Leon J Thal
NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP).
CNS drug reviews 2005;11(4):353-68.
2004: Akira Kugaya; Gerard Sanacora; Julie K Staley; Robert T Malison; Ali Bozkurt; Shaukat Khan; Amit Anand; Christopher H van Dyck; Ronald M Baldwin; John P Seibyl; Dennis Charney; Robert B Innis
Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.
Biological psychiatry 2004;56(7):497-502.
2004: Christopher H van Dyck
Understanding the latest advances in pharmacologic interventions for Alzheimer's disease.
CNS spectrums 2004;9(7 Suppl 5):24-8.
2004: Christopher H van Dyck; Robert T Malison; Julie K Staley; Leslie K Jacobsen; John P Seibyl; Marc Laruelle; Ronald M Baldwin; Robert B Innis; Joel Gelernter
Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype.
The American journal of psychiatry 2004;161(3):525-31.
2004: Michael Grundman; Ronald C. Petersen; Steven H Ferris; Ronald Thomas; Paul S Aisen; David A Bennett; Norman L Foster; Clifford R Jack; Douglas Galasko; Rachelle S Doody; Jeffrey A Kaye; Mary Sano; Richard C Mohs; S Gauthier; Hyun T Kim; Shelia Jin; Arlan N Schultz; Kimberly Schafer; Ruth Mulnard; Christopher H van Dyck; Jacobo E Mintzer; Edward Zamrini; Deborah A Cahn-Weiner; Leon J Thal
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
Archives of neurology 2004;61(1):59-66.
2003: Masahiro Fujita; Masanori Ichise; Christopher H van Dyck; Sami S Zoghbi; Gilles Tamagnan; Alexey G Mukhin; Ali Bozkurt; Nicholas Seneca; Dnyanesh N Tipre; Christopher DeNucci; Hidehiro Iida; D Bruce Vaupel; Andrew G Horti; Andrei O KoreN; Alane S Kimes; Edythe D London; John P Seibyl; Ronald M Baldwin; Robert B Innis
Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET.
European journal of nuclear medicine and molecular imaging 2003;30(12):1620-9.
2003: Akira Kugaya; C Neill Epperson; Sami S Zoghbi; Christopher H van Dyck; Yankun Hou; Masahiro Fujita; Julie K Staley; Pradeep K Garg; John P Seibyl; Robert B Innis
Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women.
The American journal of psychiatry 2003;160(8):1522-4.
2003: Michael Grundman; Clifford R Jack; Ronald C. Petersen; Hyun T Kim; Curtis Taylor; Marina Datvian; Myron Weiner; Charles DeCarli; Steven T DeKosky; Christopher H van Dyck; Sultan Darvesh; Kristine Yaffe; Jeffrey A Kaye; Steven H Ferris; Ronald Thomas; Leon J Thal
Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment.
Journal of molecular neuroscience : MN 2003;20(3):241-8.
2002: Jaakko Lappalainen; Henry R Kranzler; Robert T Malison; Lawrence H Price; Christopher H van Dyck; Robert A Rosenheck; Joyce A Cramer; Steven Southwick; Dennis Charney; John H Krystal; Joel Gelernter
A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States.
Archives of general psychiatry 2002;59(9):825-31.
2002: Michael Grundman; Drahomira Sencakova; Clifford R Jack; Ronald C. Petersen; Hyun T Kim; Arlan Schultz; Myron Weiner; Charles DeCarli; Steven T DeKosky; Christopher H van Dyck; Ronald Thomas; Leon J Thal
Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial.
Journal of molecular neuroscience : MN 2002;19(1-2):23-7.
2002: Christopher H van Dyck; Donald M Quinlan; Lisa M Cretella; Julie K Staley; Robert T Malison; Ronald M Baldwin; John P Seibyl; Robert B Innis
Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.
The American journal of psychiatry 2002;159(2):309-12.
2002: Christopher H van Dyck; John P Seibyl; Robert T Malison; Marc Laruelle; Sami S Zoghbi; Ronald M Baldwin; Robert B Innis
Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2002;10(1):36-43.
2001: Kenneth Marek; Robert B Innis; Christopher H van Dyck; B Fussell; Michele Early; Shirley Eberly; David Oakes; John P Seibyl
[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.
Neurology 2001;57(11):2089-94.
2001: Diana Martinez; Joel Gelernter; Anissa Abi-Dargham; Christopher H van Dyck; Lawrence S Kegeles; Robert B Innis; Marc Laruelle
The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(5):553-60.
2001: Jair C Soares; Christopher H van Dyck; P Tan; Sami S Zoghbi; Pradeep K Garg; Robert Soufer; Ronald M Baldwin; Masahiro Fujita; Julie K Staley; XINGZHENG FU; Louis Amici; John P Seibyl; Robert B Innis
Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and.
Psychiatry research 2001;106(2):81-93.
2001: Julie K Staley; Christopher H van Dyck; Ping-Zhong Tan; Mohammed S Al-Tikriti; Q Ramsby; H Klump; C Ng; Pradeep K Garg; Robert Soufer; Ronald M Baldwin; Robert B Innis
Comparison of [(18)F]altanserin and [(18)F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studies.
Nuclear medicine and biology 2001;28(3):271-9.
2001: Christopher H van Dyck
Neuroimaging in Alzheimer's disease: relevance for treatment.
Current psychiatry reports 2001;3(1):13-9.
2000: Christopher H van Dyck; Jair C Soares; Ping-Zhong Tan; Julie K Staley; Ronald M Baldwin; Louis Amici; XINGZHENG FU; Pradeep K Garg; John P Seibyl; Dennis S Charney; Robert B Innis
Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
Nuclear medicine and biology 2000;27(8):715-22.
2000: RA Avery; Jenna S Franowicz; Colin Studholme; Christopher H van Dyck; Amy F T Arnsten
The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;23(3):240-9.
2000: Christopher H van Dyck; Robert T Malison; John P Seibyl; Marc Laruelle; H Klumpp; Sami S Zoghbi; Ronald M Baldwin; Robert B Innis
Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT.
Neurobiology of aging 2000;21(4):497-501.
2000: Marc Laruelle; Anissa Abi-Dargham; Christopher H van Dyck; Roberto Gil; D Cyril D'Souza; John Krystal; John P Seibyl; R Baldwin; Robert B Innis
Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
Biological psychiatry 2000;47(5):371-9.
2000: Ruth Mulnard; Carl W Cotman; Claudia H Kawas; Christopher H van Dyck; Mary Sano; Rachelle S Doody; Elizabeth Koss; Eric Pfeiffer; Shelia Jin; A Gamst; Michael Grundman; R Thomas; Leon J Thal
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
JAMA : the journal of the American Medical Association 2000;283(8):1007-15.
2000: Christopher H van Dyck; Ping-Zhong Tan; Ronald M Baldwin; Louis Amici; Pradeep K Garg; CK Ng; Robert Soufer; Dennis S Charney; Robert B Innis
PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(2):234-41.
2000: Christopher H van Dyck; Paul Newhouse; W E Falk; J A Mattes
Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group.
Archives of general psychiatry 2000;57(2):157-64.
1999: Nicolaas P L G Verhoeff; Jair C Soares; CD D'Souza; R Gil; K Degen; Anissa Abi-Dargham; Sami S Zoghbi; Masahiro Fujita; N Rajeevan; John P Seibyl; John H Krystal; Christopher H van Dyck; Dennis S Charney; Robert B Innis
[123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia.
Psychiatry research 1999;91(3):163-73.
1999: Ping-Zhong Tan; Ronald M Baldwin; Christopher H van Dyck; Mohammed S Al-Tikriti; Bryan L Roth; N Khan; Dennis S Charney; Robert B Innis
Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.
Nuclear medicine and biology 1999;26(6):601-8.
1998: Robert T Malison; Lawrence H Price; Robert Berman; Christopher H van Dyck; GH Pelton; Linda Carpenter; Gerard Sanacora; M J Owens; Charles Nemeroff; N Rajeevan; Ronald M Baldwin; John P Seibyl; Robert B Innis; Dennis S Charney
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.
Biological psychiatry 1998;44(11):1090-8.
1998: Christopher H van Dyck; Joel Gelernter; Martha G MacAvoy; RA Avery; M Criden; O Okereke; Pradeep Varma; John P Seibyl; PB Hoffer
Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease.
Archives of neurology 1998;55(11):1460-6.
1998: John P Seibyl; Kenneth Marek; K Sheff; Sami S Zoghbi; Ronald M Baldwin; Dennis S Charney; Christopher H van Dyck; Robert B Innis
Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(9):1500-8.
1998: Robert T Malison; S E Best; Christopher H van Dyck; EF McCance; E A Wallace; Marc Laruelle; Ronald M Baldwin; John P Seibyl; Lawrence H Price; Thomas R Kosten; Robert B Innis
Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.
The American journal of psychiatry 1998;155(6):832-4.
1998: Anissa Abi-Dargham; R Gil; John H Krystal; Ronald M Baldwin; John P Seibyl; M Bowers; Christopher H van Dyck; Dennis S Charney; Robert B Innis; Marc Laruelle
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
The American journal of psychiatry 1998;155(6):761-7.
1997: Joel Gelernter; Christopher H van Dyck; Daniel P van Kammen; Robert T Malison; Lawrence H Price; JF Cubells; Robert Berman; Dennis S Charney; G Heninger
Ciliary neurotrophic factor null allele frequencies in schizophrenia, affective disorders, and Alzheimer's disease.
American journal of medical genetics 1997;74(5):497-500.
1997: John P Seibyl; Kenneth Marek; K Sheff; Ronald M Baldwin; Sami S Zoghbi; Yolanda Zea-Ponce; Dennis S Charney; Christopher H van Dyck; PB Hoffer; Robert B Innis
Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1453-9.
1997: Christopher H van Dyck; C H Lin; R Robinson; J Cellar; E O Smith; J C Nelson; Amy F T Arnsten; PB Hoffer
The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease.
Psychopharmacology 1997;132(3):217-26.
1997: Christopher H van Dyck; Thomas J McMahon; Marc I Rosen; Stephanie S O'Malley; Patrick G O'Connor; C H Lin; H Rowland Pearsall; Scott W Woods; Thomas R Kosten
Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study.
The Journal of neuropsychiatry and clinical neurosciences 1997;9(1):29-36.
1997: Amy F T Arnsten; C H Lin; Christopher H van Dyck; K J Stanhope
The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys.
Neurobiology of aging 1997;18(1):21-8.
1996: Christopher H van Dyck; C H Lin; E O Smith; G Wisniewski; J Cellar; R Robinson; M Narayan; A Bennett; R C Delaney; Richard A Bronen; PB Hoffer
Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(11):1749-55.
1996: Marc Laruelle; Anissa Abi-Dargham; Christopher H van Dyck; R Gil; CD D'Souza; J Erdos; E McCance; William H Rosenblatt; C Fingado; Sami S Zoghbi; Ronald M Baldwin; John P Seibyl; John H Krystal; D S Charney; Robert B Innis
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(17):9235-40.
1996: John P Seibyl; Marc Laruelle; Christopher H van Dyck; E Wallace; Ronald M Baldwin; Sami S Zoghbi; Yolanda Zea-Ponce; John L Neumeyer; D S Charney; PB Hoffer; Robert B Innis
Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(2):222-8.
1996: Christopher H van Dyck; John P Seibyl; J B Stubbs; Sami S Zoghbi; G Wisniewski; Ronald M Baldwin; Yolanda Zea-Ponce; D S Charney; PB Hoffer; Robert B Innis
Human biodistribution and dosimetry of the SPECT D2 dopamine receptor radioligand [123I]IBF.
Nuclear medicine and biology 1996;23(1):9-16.
1996: Kenneth Marek; John P Seibyl; Sami S Zoghbi; Yolanda Zea-Ponce; Ronald M Baldwin; B Fussell; D S Charney; Christopher H van Dyck; PB Hoffer; R P Innis
[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.
Neurology 1996;46(1):231-7.
1995: Robert T Malison; Christopher J McDougle; Christopher H van Dyck; Lawrence Scahill; Ronald M Baldwin; John P Seibyl; Lawrence H Price; James F Leckman; Robert B Innis
[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.
The American journal of psychiatry 1995;152(9):1359-61.
1995: Marc Laruelle; Anissa Abi-Dargham; Christopher H van Dyck; William H Rosenblatt; Yolanda Zea-Ponce; Sami S Zoghbi; Ronald M Baldwin; D S Charney; PB Hoffer; Hank F Kung
SPECT imaging of striatal dopamine release after amphetamine challenge.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1182-90.
1995: Christopher H van Dyck; John P Seibyl; Robert T Malison; Marc Laruelle; E Wallace; Sami S Zoghbi; Yolanda Zea-Ponce; Ronald M Baldwin; D S Charney; PB Hoffer
Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1175-81.
1995: John H Krystal; Scott W Woods; T R Kosten; Marc I Rosen; John P Seibyl; Christopher H van Dyck; L H Price; I George Zubal; PB Hoffer; D S Charney
Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT).
The American journal of drug and alcohol abuse 1995;21(1):47-63.
1994: Christopher H van Dyck; Marc I Rosen; H M Thomas; Thomas J McMahon; E A Wallace; Patrick G O'Connor; M Sullivan; John H Krystal; PB Hoffer; Scott W Woods
SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine.
Psychiatry research 1994;55(4):181-91.
1994: Marc Laruelle; Christopher H van Dyck; Anissa Abi-Dargham; Yolanda Zea-Ponce; Sami S Zoghbi; D S Charney; Ronald M Baldwin; PB Hoffer; Hank F Kung; Robert B Innis
Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(5):743-54.
1990: Sharon K Inouye; Christopher H van Dyck; C A Alessi; S Balkin; A P Siegal; Ralph I Horwitz
Clarifying confusion: the confusion assessment method. A new method for detection of delirium.
Annals of internal medicine 1990;113(12):941-8.